Thank you, Mr. Chairman.
Mr. Gagnon, we appreciate the research that's being done. As my colleague and others have said, it's been of real benefit to women and to all Canadians to have this research done.
I would be interested to know how much research you think would be done in Canada without the tax incentives for companies, since most pharmaceutical companies have an international component. What would be the impact on pharmaceutical research in Canada without the tax incentives that you're talking about?